Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Marijuana Abuse × Medical Marijuana × Clear all

Phase

Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Tourette Syndrome 1 Stress Disorders, Post-Traumatic 1 Sleep Initiation and Maintenance Disorders 1 Severe Acute Respiratory Syndrome 1 Seizures 1 Parkinson Disease 1 Pancreatic Cancer Non-resectable 1 Opioid-Related Disorders 1 Neoplasms 1 Multiple Sclerosis 1 Marijuana Abuse 1 Inflammatory Bowel Diseases 1 Hepatitis C 1 Glaucoma 1 Fibromyalgia 1 Epilepsy 1 Depression 1 Crohn Disease 1 Coronavirus Infections 1 Colitis, Ulcerative 1 Chronic Traumatic Encephalopathy 1 Chronic Pain 1 Carcinoma, Hepatocellular 1 COVID-19 1 Brain Injuries, Traumatic 1 Bipolar Disorder 1 Autistic Disorder 1 Anxiety Disorders 1 Anemia, Sickle Cell 1 Amyotrophic Lateral Sclerosis 1

Interventions

nabiximols 3 Temozolomide 1 Medical Marijuana 1 Dronabinol 1 Cannabidiol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06518434 2024-07-24

CanHep

University Medical Center Groningen

Phase 2 Recruiting

Gastrointestinal

Marijuana Abuse, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡